C1 Esterase Inhibitor (C1EI) is a blood product that is licensed in Canada for the treatment of Hereditary Angioedema.
A provincial immunology and allergy working group, chaired by the PBCO, has endorsed the following algorithms. In addition, a sample letter is available, should an Immunologist wish to adapt and implement it for use in their practice. Please note, these resources (including alternatives) are currently under review.
| Algorithms |
Dated |
|
Hereditary Angioedema Diagnosis Algorithm |
Archived |
|
Hereditary Angioedema Treatment Recommendations |
Archived |
|
Hereditary Angioedema Long Term Prophylaxis Recommendations |
Archived |
| Sample Letter | |
|
Hereditary Angioedema Sample Letter for Patients (from diagnosing physician) |
Archived |
TMS IVIG Request Process
| Additional Resources | |
|
2019 International/Canadian Hereditary Angioedema Guideline (revision in progress) |
